Catalyst Pharmaceuticals (CPRX) EPS (Diluted) (2018 - 2026)
Catalyst Pharmaceuticals (CPRX) recorded EPS (Diluted) of $0.50 in Q1 2026, up 12.4% from $0.45 a year earlier and up 21.3% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) EPS (Diluted) (2018 - 2026) Analysis & Trends
On a TTM basis, Catalyst Pharmaceuticals' EPS (Diluted) came in at $1.74 as of Mar 31, 2026, up 12.2% year-over-year; for FY2025, it came in at $1.68, up 28.4% from FY2024.
- Annual EPS (Diluted) has a five-year compound annual growth rate of 19.0% (FY2020 to FY2025).
- Across earlier years, EPS (Diluted) came in at $1.31 in FY2024 (+108.9%), $0.63 in FY2023 (-15.8%), $0.75 in FY2022 (+103.7%) and $0.37 in FY2021 (-48.1%).
- The Q1 2026 figure is the highest quarterly EPS (Diluted) in data going back to Q2 2018.
- On a year-over-year basis, EPS (Diluted) rose in five of the last seven quarters, with growth averaging 32.9%.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 164.8% in Q4 2022, against a decline of 76.5% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $0.41 (Q4 2025), $0.42 (Q3 2025) and $0.41 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 0.50 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.45 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.31 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.26 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.10 |
| Jun 30, 2021 | 0.11 |
API Access
Catalyst Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();